Laura Dichtel MD
Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Assistant Professor, Harvard Medical School and Massachusetts General Hospital
Join to View Full Profile
55 Fruit St# BUL457Boston, MA 02114
Phone+1 617-724-3614
Fax+1 617-726-5072
Dr. Dichtel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Yale School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2012 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease Start of enrollment: 2022 Aug 10
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Expansion of a physician parental wellness programme at the Massachusetts General Hospital to improve physician well-being.Josephine H Li, Megan F Hoang, Lauren E Olson, Kerri Palamara, Erin E Sullivan
BMJ Leader. 2025-12-31 - 4 citationsReal-World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression.Kathleen E Corey, Nabih Nakrour, Emily D Bethea, Jessica E Shay, Karin L Andersson
Liver International. 2025-09-01 - Neuroactive steroid levels are elevated in the follicular phase and predict premenstrual depression and anxiety symptom severity in women with menstrually related mood...Allison Kimball, Jenna Bourassa, Mark L Chicote, Anu V Gerweck, Laura E Dichtel
Archives of Women's Mental Health. 2025-08-01
Press Mentions
Top in Endocrinology: Nonalcoholic Fatty Liver Disease in Patients with Obesity, DiabetesJune 29th, 2022- Lumos Pharma, Inc. (LUMO) CEO Richard Hawkins on Q1 2022 Results - Earnings Call TranscriptMay 11th, 2022
- Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated TrialMay 5th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
